GE HealthCare (GEHC) Q2 2026: Backlog Hits $23.9B as One Unit Struggles
As seen on the 24/7 Wall St. homepage on July 29, 2026.
GE HealthCare beat both EPS and revenue estimates on record order momentum, with a $23.9 billion backlog and 11% organic orders growth signaling durable demand, though a 13% revenue decline at Patient Care Solutions triggered a strategic review of the struggling unit.
Continue ReadingShow less
GE HealthCare reported Q2 2026 earnings per share of $1.13, topping the $1.04 consensus estimate by about 9%. Revenue came in at $5.295 billion, edging past the $5.256 billion estimate. The beat extends a consistent pattern of outperformance: the company has now exceeded EPS expectations in seven of the past eight quarters, with the lone miss coming in Q1 2026 when it reported $0.99 against a $1.05 estimate.
The headline story is order momentum. Organic orders grew 11%, pushing the total backlog to a record $23.9 billion — a figure that signals customers are committing to equipment and services well into the future. That kind of backlog depth typically gives management more visibility into forward revenue and reduces the risk of near-term demand shocks.
Sponsored
Twelve Tabs, One Thesis
Your Research Resets Every Morning
The quote page in one tab. Filings in another. A chart you rebuilt from scratch, a transcript you never went back and found, a screener whose settings you will redo next week. Nothing you built yesterday is still there.
AlphaSpace replaces all of it with one screen you arrange yourself. Earnings calendar, estimate versus actual, the call transcript, live news, your own charts, every panel wired to whatever ticker you click. Close the browser and it is all still sitting there tomorrow.
See What a Built View Looks Like →
(Sponsor)
Not everything is moving in the right direction, however. The Patient Care Solutions segment posted a 13% revenue decline, a drop significant enough that the company has launched a strategic review of the unit. How that review concludes — whether through a turnaround plan, a restructuring, or a potential divestiture — is likely to be the key storyline for GEHC investors in the quarters ahead.
Mentioned: GEHC